Eledon Pharmaceuticals Provides Business and Pipeline Updates
09 janv. 2023 08h31 HE
|
Eledon Pharmaceuticals, Inc.
Company plans to prioritize and focus resources on the advancement of tegoprubart in kidney transplantation Continued enrollment in open-label Phase 1b kidney transplant trial with initial data...
Insights on the Flow Cytometry Global Market to 2027 - Increasing Use of Flow Cytometry in Cellular Therapy Development Presents Opportunities
05 janv. 2023 08h28 HE
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Flow Cytometry: Products, Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report aims to provide a...
C-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System
21 déc. 2022 16h05 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path) announced on December 20, 2022, that its Transplant Therapeutic Consortium (TTC) received a qualification opinion...
Immucor and Pirche announce multi-year partnership
04 oct. 2022 08h04 HE
|
Immucor, Inc.
NORCROSS, Ga. and BERLIN, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, and Pirche AG, the global leader in AI-powered molecular...
Global Organ Transplant Market Report 2022: Rising Need for Innovative Tissue Transplantation Products and Organ Transplantation to Treat Organ Failure Propelling Sector
06 sept. 2022 05h23 HE
|
Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Global Organ Transplant Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.A major element driving...
Surreal Photography Exhibit Brings Awareness
01 sept. 2022 09h30 HE
|
Texas Organ Sharing Alliance
Austin, TX, Sept. 01, 2022 (GLOBE NEWSWIRE) -- AUSTIN, TX (September 1, 2022) – A Central Texas couple who create fine-art surreal photographs is collaborating with the Austin-Bergstrom...
Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29 août 2022 08h00 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming investor...
The Worldwide Organ Transplant Diagnostics Industry is Expected to Reach $6 Billion by 2031
12 août 2022 07h08 HE
|
Research and Markets
Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Organ Transplant Diagnostics Market 2021-2031 by Offering, Transplant, Application, Technology, End User, and Region: Trend Forecast and Growth...
Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results
11 août 2022 16h01 HE
|
Eledon Pharmaceuticals, Inc.
Received FDA clearance of IND application for Phase 2 trial evaluating tegoprubart for the prevention of rejection in kidney transplant recipients First patient dosed in Phase 1b trial evaluating...
Eledon Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
04 août 2022 16h05 HE
|
Eledon Pharmaceuticals, Inc.
Management to host conference call and webcast at 4:30 pm ET IRVINE, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical...